2ND-LOOK LAPAROTOMY IN THE PATIENT WITH MINIMAL RESIDUAL STAGE-III OVARIAN-CANCER (A GYNECOLOGIC ONCOLOGY GROUP-STUDY)

被引:24
作者
CREASMAN, WT
GALL, S
BUNDY, BN
BEECHAM, J
MORTEL, R
HOMESLEY, HD
机构
[1] UNIV ILLINOIS,DIV MATERNAL FETAL MED,CHICAGO,IL 60680
[2] UNIV ILLINOIS,DEPT OBSTET & GYNECOL,CHICAGO,IL 60680
[3] UNIV ROCHESTER,MED CTR,ROCHESTER,NY 14642
[4] PENN STATE UNIV,MILTON S HERSHEY MED CTR,DEPT OBSTET & GYNECOL,HERSHEY,PA 17033
[5] WAKE FOREST UNIV,BOWMAN GRAY SCH MED,DEPT OBSTET & GYNECOL,WINSTON SALEM,NC 27103
[6] WAKE FOREST UNIV,BOWMAN GRAY SCH MED,GYNECOL ONCOL SECT,WINSTON SALEM,NC 27103
[7] ROSWELL PK MEM INST,GYNECOL ONCOL GRP,BUFFALO,NY
关键词
D O I
10.1016/0090-8258(89)90083-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:378 / 382
页数:5
相关论文
共 11 条
[1]   IMPROVED THERAPY WITH CISPLATIN REGIMENS FOR PATIENTS WITH OVARIAN-CARCINOMA (FIGO STAGE-III AND STAGE-IV) AS MEASURED BY SURGICAL END-STAGING (2ND-LOOK OPERATION) [J].
COHEN, CJ ;
GOLDBERG, JD ;
HOLLAND, JF ;
BRUCKNER, HW ;
DEPPE, G ;
GUSBERG, SB ;
WALLACH, RC ;
KABAKOW, B ;
RODIN, J .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1983, 145 (08) :955-967
[2]  
COX DR, 1972, J R STAT SOC B, V34, P187
[3]  
Cox DR., 1990, BIOMETRICS, V46, P550, DOI [10.2307/2531476, DOI 10.2307/2531476]
[4]  
EHRLICH CE, 1983, CLIN OBSTET GYNAECOL, V10, P325
[5]   THERAPY OF STAGE-III (OPTIMAL) EPITHELIAL CARCINOMA OF THE OVARY WITH MELPHALAN OR MELPHALAN PLUS CORYNEBACTERIUM PARVUM - (A GYNECOLOGIC ONCOLOGY GROUP-STUDY) [J].
GALL, S ;
BUNDY, B ;
BEECHAM, J ;
WHITNEY, C ;
HOMESLEY, H ;
LIFSHITZ, S ;
ADCOCK, LL .
GYNECOLOGIC ONCOLOGY, 1986, 25 (01) :26-36
[6]  
GERSHENSON DM, 1985, CANCER, V55, P1129, DOI 10.1002/1097-0142(19850301)55:5<1129::AID-CNCR2820550531>3.0.CO
[7]  
2-O
[8]  
Griffiths C T, 1975, Natl Cancer Inst Monogr, V42, P101
[9]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481
[10]  
LUESLEY DM, 1984, OBSTET GYNECOL, V64, P421